Titanium 5 L5 HB [20 mL] (10 Doses)

Titanium 5 L5 HB contains desiccated Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3-Respiratory Syncytial Virus Vaccine and a bacterin diluent (Lepto 5 HB). Titanium 5 L5 HB is a multiantigenic modified live vaccine to be used as an aid in the prevention of disease caused by infectious bovine rhinotracheitis virus (IBR), bovine virus diarrhea virus (BVD), bovine parainfluenza3 virus (PI3), and bovine respiratory syncytial virus (BRSV) and a bacterin to aid in the prevention of disease caused by Leptospira borgpetersenii serovar hardjo-bovis and Leptospira canicola, Leptospira grippotyphosa, Leptospira hardjo, Leptospira icterohaemorrhagiae, and Leptospira pomona.

The five viral antigens are combined in the proper ratio, stabilized and desiccated into one cake. The desiccated viral fractions are rehydrated for use with a specially processed liquid Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin, Lepto 5. The desiccated fraction contains no bovine serum, virtually eliminating extraneous virus contamination and possible allergic reactions. Controlled tests conducted in our laboratory demonstrated that animals receiving a 10x dose did not shed BRSV or PI3 viruses. Control animals, housed with vaccinates, remained seronegative throughout the testing period.

The fetal loss in the two groups was similar with 3.43% in the Titanium 5 L5 HB vaccinated groups and 4.65% in the control groups. Following calving, each calf’s health was monitored for 4 weeks. The health of the calves in the Titanium 5 L5 HB vaccinated dams was similar to the health of calves born to the control dams.

Titanium 5 L5 HB [20 mL] (10 Doses) Highlights:

• SKU: 13255
• Manufacturer: Elanco
• Annual revaccination is recommended
• Proven protection against BVDV type 1b and type 2
• Studies showed Titanium provides 110-day duration of immunity against IBR
• The cows were observed from pregnancy vaccination through calving for fetal loss
• Modified Live Bovine Respiratory Syncytial Virus (BRSV) in combinations with IBIR, PI3, BVD (Type 1&2) and 5-way Lepto.
• Controlled tests conducted in our laboratory demonstrated that animals receiving a 10x dose did not shed BRSV or PI3viruses
• Calves vaccinated before weaning should be revaccinated 30 days after weaning when the possible influence of maternal antibodies is decreased